Liaoning He Eye Hospital Group Co., LTD. (SHE:301103)
China · Delayed Price · Currency is CNY 21.34
-0.20 (-0.93%)
At close: Feb 12, 2026
SHE:301103 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,078 | 1,088 | 1,179 | 949.91 | 958.69 | 834.72 |
Other Revenue | 7.82 | 7.82 | 6.63 | 5.41 | 3.77 | 3.75 |
| 1,086 | 1,096 | 1,185 | 955.31 | 962.45 | 838.47 | |
Revenue Growth (YoY) | -1.80% | -7.56% | 24.07% | -0.74% | 14.79% | 12.46% |
Cost of Revenue | 660.93 | 674.34 | 691.5 | 588.89 | 575.01 | 474.72 |
Gross Profit | 425.08 | 421.29 | 493.73 | 366.43 | 387.45 | 363.75 |
Selling, General & Admin | 379.18 | 401.11 | 392.28 | 301.73 | 251.46 | 224.24 |
Research & Development | 14.86 | 18.11 | 12.62 | 0.66 | 0.63 | 0.99 |
Other Operating Expenses | 6.97 | 7.6 | 5.82 | 5.74 | 5.09 | 3.86 |
Operating Expenses | 401.08 | 426.85 | 412.16 | 308.38 | 257.14 | 229.39 |
Operating Income | 24 | -5.56 | 81.57 | 58.04 | 130.3 | 134.36 |
Interest Expense | -9.61 | -11.34 | -13.6 | -12.18 | -12.1 | -0.64 |
Interest & Investment Income | 24.53 | 21.65 | 34.92 | 23.58 | 9.9 | 5.5 |
Currency Exchange Gain (Loss) | -0 | -0 | 0.06 | - | - | - |
Other Non Operating Income (Expenses) | -1.22 | -3.7 | -3.86 | -3.11 | -3.23 | -2.86 |
EBT Excluding Unusual Items | 37.7 | 1.05 | 99.09 | 66.33 | 124.87 | 136.37 |
Gain (Loss) on Sale of Investments | 1.62 | 0.99 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.09 | 1.4 | 3.53 | -0.06 | -0.31 | -0.06 |
Asset Writedown | -0.01 | -0.71 | -1.45 | -0.24 | -0.21 | -0.51 |
Other Unusual Items | -2.25 | -1.1 | 4.22 | 5.52 | 11.96 | 12.59 |
Pretax Income | 36.96 | 1.63 | 105.38 | 71.55 | 136.32 | 148.39 |
Income Tax Expense | 29.21 | 36.9 | 47.59 | 39.44 | 49.95 | 48.16 |
Earnings From Continuing Operations | 7.75 | -35.28 | 57.79 | 32.11 | 86.36 | 100.24 |
Minority Interest in Earnings | 2.87 | 7.88 | 5.76 | 0.49 | - | - |
Net Income | 10.62 | -27.4 | 63.55 | 32.59 | 86.36 | 100.24 |
Net Income to Common | 10.62 | -27.4 | 63.55 | 32.59 | 86.36 | 100.24 |
Net Income Growth | - | - | 94.99% | -62.26% | -13.84% | 24.36% |
Shares Outstanding (Basic) | 159 | 158 | 158 | 148 | 118 | 118 |
Shares Outstanding (Diluted) | 159 | 158 | 158 | 148 | 118 | 118 |
Shares Change (YoY) | 1.26% | -0.00% | 6.71% | 25.10% | 0.00% | 0.86% |
EPS (Basic) | 0.07 | -0.17 | 0.40 | 0.22 | 0.73 | 0.85 |
EPS (Diluted) | 0.07 | -0.17 | 0.40 | 0.22 | 0.73 | 0.85 |
EPS Growth | - | - | 82.73% | -69.83% | -13.84% | 23.30% |
Free Cash Flow | 110.42 | 39.31 | -11.74 | 98.87 | 142.38 | 76.58 |
Free Cash Flow Per Share | 0.69 | 0.25 | -0.07 | 0.67 | 1.20 | 0.65 |
Dividend Per Share | 0.150 | 0.150 | 0.600 | 1.000 | 0.462 | - |
Dividend Growth | -75.00% | -75.00% | -40.00% | 116.68% | - | - |
Gross Margin | 39.14% | 38.45% | 41.66% | 38.36% | 40.26% | 43.38% |
Operating Margin | 2.21% | -0.51% | 6.88% | 6.08% | 13.54% | 16.02% |
Profit Margin | 0.98% | -2.50% | 5.36% | 3.41% | 8.97% | 11.96% |
Free Cash Flow Margin | 10.17% | 3.59% | -0.99% | 10.35% | 14.79% | 9.13% |
EBITDA | 76.79 | 46.92 | 133.63 | 109.77 | 179.92 | 174.85 |
EBITDA Margin | 7.07% | 4.28% | 11.28% | 11.49% | 18.69% | 20.85% |
D&A For EBITDA | 52.79 | 52.48 | 52.06 | 51.73 | 49.61 | 40.49 |
EBIT | 24 | -5.56 | 81.57 | 58.04 | 130.3 | 134.36 |
EBIT Margin | 2.21% | -0.51% | 6.88% | 6.08% | 13.54% | 16.02% |
Effective Tax Rate | 79.03% | 2267.93% | 45.16% | 55.13% | 36.64% | 32.45% |
Revenue as Reported | 1,086 | 1,096 | 1,185 | 955.31 | 962.45 | 838.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.